Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 29,343

Document Document Title
WO/2015/139827A1
The invention relates to a liquid crystal medium which contains at least one compound of the formula (I), in which R1 and R1* independently of each other represent an alkyl or alkyl group with 1 to 15 C atoms, wherein in said groups, one...  
WO/2015/137923A1
Nylon 12 may be produced by dimerization of 6-carbon furan compounds into 12-carbon dimers, and conversion of the dimers into nylon 12. The 6-carbon furan compounds may be produced from biomass. Ester-aldehyde dimers and amino-ester dime...  
WO/2015/137914A1
Nylon 7 may be produced from biomass derived 6-carbon hydroxymethyl furan compounds as the raw material. The hydroxymethyl furan compounds may be homologated to form an aldehyde that may be aminated to produce an amino carbonyl compound....  
WO/2015/133413A1
 Provided are: a method for producing furfural by bringing superheated steam into contact with biomass feedstock including hemicellulose obtained by bringing an acid catalyst and a wet agent comprising at least one of a surfactant, an ...  
WO/2015/133902A1
Psicose is converted into 5-hydroxymethylfurfural or an alkyl ether thereof in a process for the catalysed conversion of psicose, comprising the steps of: a. forming a feed comprising psicose and water or at least one alkanol or a mixtur...  
WO/2015/133540A1
The present invention relates to a method for producing furfural, said method having a reaction step in which a catalyst that includes sulfuric acid and a biomass feedstock that includes hemicellulose are supplied into a metal reactor, a...  
WO/2015/134314A1
This invention provides a process for producing biomass pellets and fermentable sugars from cellulosic biomass, comprising: extracting cellulosic biomass feedstock with steam and/or hot water to produce an extract liquor containing hemic...  
WO/2015/132396A1
Prodrugs (I) and (Ia) of galiellactone, and derivatives thereof, are provided by reacting the parent compound, e.g. galiellactone, with a thiol. Such drugs may be administered orally to treat cancer and other proliferative diseases.  
WO/2015/131286A1
Disclosed are salts of a compound of formula 1, as shown below, where R1, R2, R3, R4, R5, R6 and R7 are as described herein. Also, disclosed is a process for the preparation of the salts of the compounds of formula 1, and intermediates u...  
WO/2015/127553A1
Disclosed is the use of a fruit kernel for producing biofuel or an intermediate in the production thereof. The fruit kernel is generally obtained from an avocado or mango and is used as a dry powder. Also disclosed are methods for produc...  
WO/2015/129896A1
In the present invention, a compound represented by a formula (1) (in the formula, R1, R2, Ar1, and Ar2 are as defined in the description) enables an organic electroluminescent element, for which low voltage driving is possible and which...  
WO/2015/129813A1
The present invention provides: a deuteration method that is both cost effective and has an excellent deuteration rate; a method for selectively replacing a leaving group of an aromatic compound with deuterium; and a deuteration catalyst...  
WO/2015/129832A1
 The present invention is a radiosensitive resin composition containing: a polymer having a structural unit that contains the group represented by formula (1); and a radiosensitive acid generator. In formula (1), R1 is a substituted or...  
WO/2015/126129A2
The present invention relates to a resveratrol multimer having a selective inhibitory activity for hepatitis C virus genome replication, and a use thereof, and more particularly, to a resveratrol multimer having a selective inhibitory ac...  
WO/2015/127137A1
The present invention provides compounds of formula I that bind to mitochondrial aldehyde dehydrogenase-2 (ALDH2), and methods of using said compounds to treat patients with i.a. cancer, Fanconi anemia and alcohol-related disorders. [For...  
WO/2015/125734A1
The present invention provides: a halohexahydrophthalic acid derivative that is a synthesis intermediate for an alicyclic or semialicyclic tetracarboxylic acid dianhydride, and that can be used as a raw material monomer for a polyimide w...  
WO/2015/122494A1
Provided is a novel compound having an excellent suppression action against arrhythmia including atrial fibrillation and being useful as a pharmaceutical product having a separated antiviral effect. A compound indicated by general formul...  
WO/2015/122522A1
The present invention addresses the issue of providing a highly pure gamma-butylolactone (GBL) that is capable of preventing the occurrence of unintended reactions during use, caused by high GBL acidity. This gamma-butylolactone composit...  
WO/2015/123389A1
A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.  
WO/2015/122187A1
A fused heterocyclic compound having an enteropeptidase inhibitory action and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided. Specifically, a compound represented by the...  
WO/2015/117912A1
Compounds of formula (I), wherein (II) is a five-membered, aromatic ring system which may contain 2 or 3 heteroatoms selected from the group consisting of nitrogen, oxygen and sulphur,and where each ring system may not contain more than ...  
WO/2015/115507A1
Provided is a compound represented by formula (I) [wherein each symbol is as defined in the description] or a pharmaceutically acceptable salt thereof. This compound has an excellent TRPA1 antagonistic activity, which makes it possible t...  
WO/2015/115805A1
The present invention relates to a novel 2-phenylbenzofuran derivative or a pharmaceutically acceptable salt thereof, to a production method for same and to a pharmaceutical composition for preventing or treating an inflammatory disease ...  
WO/2015/115589A1
The present invention provides a halogen atom-substituted polymerizable compound having improved solubility in solvents and liquid crystals and able to be used in a liquid crystal aligning agent. The present invention provides a polymeri...  
WO/2015/113903A1
The invention relates to a method for producing 1-indanoles and 1-indanamines by palladium-catalyzed arylation and to the use thereof as intermediate products for the synthesis of fine chemicals and of agrochemical active substances.  
WO/2015/115613A1
The present invention provides: a good balanced resist which has high sensitivity without deteriorating basic physical properties of a chemically amplified resist such as resolution and line edge roughness (LER); and a compound for resis...  
WO/2015/111086A1
The present invention discloses one pot process for the conversion of hemicellulose into C5 sugars using ionic liquids in water media.  
WO/2015/110502A1
A composition comprising a polymer, or an oligomer, comprising cross-linking moiety, which moiety comprises a carbon-carbon triple bond; and a molecule comprising a carbon-carbon triple bond, wherein the thermal curing behavior of said m...  
WO/2015/113060A3
The present invention relates generally to processes for converting fructose-containing feedstocks to a product comprising 5-(hydroxymethyl)furfural (HMF) and water in the presence of water, solvent and an acid catalyst. In some embodime...  
WO/2015/111078A1
The present invention relates to an improved process for the preparation of 2,5-dimethylfuran and furfuryl alcohol over ruthenium supported catalysts. Further, the present invention disclosed a process for the selective hydrogenolysis of...  
WO/2015/113060A2
The present invention relates generally to processes for converting fructose-containing feedstocks to a product comprising 5-(hydroxymethyl)furfural (HMF) and water in the presence of water, solvent and an acid catalyst. In some embodime...  
WO/2015/108136A1
The present invention provides: a novel α-substituted glycinamide derivative or a pharmacologically acceptable salt thereof; a pharmaceutical composition containing the compound or the pharmacologically acceptable salt; and a use of the...  
WO/2015/109210A1
The disclosed subject matter provides N-hydroxymethanesulfonamide compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed...  
WO/2015/107541A1
The present invention relates to compounds of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use ...  
WO/2015/108208A1
The present invention relates to a pharmaceutical composition containing dehydrodiconiferyl alcohol, a derivative thereof, optical isomers thereof, pharmaceutically acceptable salts thereof, or hydrates or solvates thereof, a treatment m...  
WO/2015/104684A1
Disclosed are compounds having the formula (I): wherein R1, R2 and R3 are as defined herein, and methods of making and using the same, including use as inhibitors of BMP1, TLL1 and/or TLL2 and in treatment of diseases associated with BMP...  
WO/2015/101916A1
An improved process for the preparation of empagliflozin is disclosed. Novel intermediates of formulas (13) and (14) for the preparation of empagliflozin are also disclosed, wherein R1 and R2 are independently hydrogen or hydroxyl protec...  
WO/2015/098716A1
A method for producing a halogen-substituted phthalide, which comprises the following steps (A) and (B). Step (A): A step wherein a halogen-substituted phthalic acid anhydride and sodium borohydride are reacted with each other in the pre...  
WO/2015/098975A1
This organic electroluminescent element comprises a positive electrode, a light emitting layer and a negative electrode. The light emitting layer contains a first material, a second material and a third material. The first material is a ...  
WO/2015/098681A1
 The problem of providing a cockroach-aggregating pheromone and a cockroach-aggregating attractant or a cockroach exterminating agent which includes the cockroach-aggregating pheromone is solved by a compound represented by any of gene...  
WO/2015/099485A1
The present invention relates to a novel organic electroluminescent compound and an organic electroluminescent device comprising the same. By using the organic electroluminescent compound according to the present invention, it is possibl...  
WO/2015/095261A1
Novel tricyclic compounds of Formula (I) and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing osteoporosis and similar conditions. The compounds are effective as calcium sensing receptor antago...  
WO/2015/094965A1
A process for preparing furanic mono- and/or di-sulfonate molecules from the reduction products of HMF, in particular, from either 2,5-bis-hydroxymethyltetrahydrofurans (THF-diols) or furan-2,5-dimethanol (FDM) under relatively mild cond...  
WO/2015/089842A1
Novel tricyclic compounds of the formula (I): and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing osteoporosis and similar conditions. The compounds are effective as calcium sensing receptor a...  
WO/2015/094970A1
Linear mono- and dialkyl ethers of furan-2,5-dimethanol (FDM) and/or 2,5-bis(hydroxymethyl)tetrahydrofuran (bHMTHF), methods for their preparation, and derivative chemical compounds thereof are described. In general, the synthesis proces...  
WO/2015/087857A1
Provided is an aryl amidine compound that has excellent bactericidal activity, is highly safe, can be synthesized in an industrially advantageous manner, and is represented by formula (II) or the like. Also provided is a bactericidal age...  
WO/2015/087248A1
Described is a method for producing furfural from one or more substances selected from the group consisting of xylose, oligosaccharides comprising xylose units and polysaccha- rides comprising xylose units.  
WO/2015/088000A1
The objective of the present invention is to provide a novel low molecular weight compound which exhibits an orexin agonist activity and is expected to be useful as an excellent therapeutic or preventive agent for narcolepsy. The present...  
WO/2015/087094A1
The invention relates to novel arylalkenylpropargylamine derivatives of general formula (I) or enantiomers or diastereomers thereof or salts, optionally pharmaceutically acceptable salts, or solvates of any of these. The compounds can be...  
WO/2015/085860A1
Disclosed are a heterocyclic hydroxamic acid compound having a general formula I, and pharmaceutically acceptable acid or alkali salts or stereoisomers thereof. The present compound and pharmaceutically acceptable salts thereof effective...  

Matches 151 - 200 out of 29,343